JP2008531713A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531713A5
JP2008531713A5 JP2007558191A JP2007558191A JP2008531713A5 JP 2008531713 A5 JP2008531713 A5 JP 2008531713A5 JP 2007558191 A JP2007558191 A JP 2007558191A JP 2007558191 A JP2007558191 A JP 2007558191A JP 2008531713 A5 JP2008531713 A5 JP 2008531713A5
Authority
JP
Japan
Prior art keywords
substituted
group
alkyl
amino
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007558191A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531713A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/007337 external-priority patent/WO2006094082A2/en
Publication of JP2008531713A publication Critical patent/JP2008531713A/ja
Publication of JP2008531713A5 publication Critical patent/JP2008531713A5/ja
Pending legal-status Critical Current

Links

JP2007558191A 2005-02-28 2006-02-27 抗菌活性を有する、半合成デスメチル−バンコマイシンベースのグリコペプチド Pending JP2008531713A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65727405P 2005-02-28 2005-02-28
PCT/US2006/007337 WO2006094082A2 (en) 2005-02-28 2006-02-27 Semi-synthetic desmethyl-vancomycin-based glycopeptides with antibiotic activity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009035926A Division JP2009102448A (ja) 2005-02-28 2009-02-18 抗菌活性を有する、半合成デスメチル−バンコマイシンベースのグリコペプチド

Publications (2)

Publication Number Publication Date
JP2008531713A JP2008531713A (ja) 2008-08-14
JP2008531713A5 true JP2008531713A5 (cg-RX-API-DMAC7.html) 2009-04-09

Family

ID=36941795

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007558191A Pending JP2008531713A (ja) 2005-02-28 2006-02-27 抗菌活性を有する、半合成デスメチル−バンコマイシンベースのグリコペプチド
JP2009035926A Pending JP2009102448A (ja) 2005-02-28 2009-02-18 抗菌活性を有する、半合成デスメチル−バンコマイシンベースのグリコペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009035926A Pending JP2009102448A (ja) 2005-02-28 2009-02-18 抗菌活性を有する、半合成デスメチル−バンコマイシンベースのグリコペプチド

Country Status (8)

Country Link
US (2) US20070185015A1 (cg-RX-API-DMAC7.html)
EP (1) EP1868630A2 (cg-RX-API-DMAC7.html)
JP (2) JP2008531713A (cg-RX-API-DMAC7.html)
AU (1) AU2006218533A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0607695A2 (cg-RX-API-DMAC7.html)
CA (1) CA2599297A1 (cg-RX-API-DMAC7.html)
MX (1) MX2007010500A (cg-RX-API-DMAC7.html)
WO (1) WO2006094082A2 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778874B2 (en) 2004-11-29 2014-07-15 National University Corporation Nagoya University Glycopeptide antibiotic monomer derivatives
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
WO2009085562A1 (en) * 2007-12-26 2009-07-09 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
WO2010048340A2 (en) * 2008-10-24 2010-04-29 Lead Therapeutics, Inc. Novel semi-synthetic glycopeptides as antibacterial agents
GB2465863A (en) * 2008-12-05 2010-06-09 Lead Therapeutics Inc Semi-synthetic heptapeptidic glycopeptides for the treatment of bacterial infections
WO2011140009A1 (en) * 2010-05-04 2011-11-10 Biomarin Pharmaceutical Inc. Methods of using semi-synthetic glycopeptides as antibacterial agents
KR102661786B1 (ko) * 2017-05-22 2024-04-26 인스메드 인코포레이티드 글리코펩티드 유도체 화합물 및 이의 용도
CN107987131B (zh) * 2017-11-16 2021-03-09 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的化合物、其制备方法和应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
GB8522574D0 (en) * 1985-09-12 1985-10-16 Lepetit Spa Amides of teicoplanin compounds
US5500410A (en) * 1989-03-29 1996-03-19 Gruppo Lepetit S.P.A. Substituted alkylamide derivatives of teicoplanin
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5488131A (en) * 1994-03-23 1996-01-30 California Institute Of Technology Synthesis of compounds with predetermined chirality
JP3031202B2 (ja) * 1994-08-08 2000-04-10 株式会社デンソー 携帯無線局
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5974507A (en) * 1997-04-14 1999-10-26 International Business Machines Corporation Optimizing a cache eviction mechanism by selectively introducing different levels of randomness into a replacement algorithm
US6026445A (en) * 1997-11-17 2000-02-15 International Business Machines Corporation System and method for saving and reusing recently acquired name to address mappings
PL198311B1 (pl) * 1998-12-23 2008-06-30 Theravance Związki glikopeptydowe, zawierające je kompozycje farmaceutyczne oraz ich zastosowanie
US6699836B2 (en) * 1999-04-02 2004-03-02 The Trustees Of Princeton University Vancomycin analogs
AU5029700A (en) * 1999-05-19 2000-12-05 Merck & Co., Inc. Glycopeptide antibacterial compounds, compositions containing same and methods of using same
US20030008812A1 (en) * 2001-02-02 2003-01-09 Christensen Burton G. Glycopeptide derivatives
US7348309B2 (en) * 2001-03-30 2008-03-25 Wisconsin Alumni Research Foundation Glycorandomization and production of novel vancomycin analogs
KR20060091049A (ko) * 2002-08-30 2006-08-17 케이.유.루벤 리서치 앤드 디벨럽먼트 글리코펩티드 항생제 및 그것의 반합성 유도체 및 항바이러스제로서의 그것의 사용
WO2004044222A2 (en) * 2002-11-12 2004-05-27 Enzon Pharmaceuticals, Inc. Polymeric prodrugs of vancomycin
US7521418B2 (en) * 2003-05-27 2009-04-21 Theravance, Inc. Use of a polyene macrolide antifungal agent in combination with a glycopeptide antibacterial agent
US7368422B2 (en) * 2005-02-28 2008-05-06 Novartis Vaccines And Diagnostics Inc. Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity
US7632918B2 (en) * 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
US7461206B2 (en) * 2006-08-21 2008-12-02 Amazon Technologies, Inc. Probabilistic technique for consistency checking cache entries

Similar Documents

Publication Publication Date Title
DE69809959T2 (de) Neue taxanderivate
JP2008531702A5 (cg-RX-API-DMAC7.html)
JP2005526857A5 (cg-RX-API-DMAC7.html)
RU2005128190A (ru) Ингибиторы фактора подавления миграции макрофагов (фпм) и способы их идентификации
JP2016510323A5 (cg-RX-API-DMAC7.html)
WO1982001873A1 (en) 1-sulfo-2-oxoazetidine derivatives and process for their preparation
EP2698375A3 (en) TGR5 modulators and method of use thereof
JP2009511508A5 (cg-RX-API-DMAC7.html)
CA2472341A1 (en) Phosphorus-containing compounds & uses thereof
JP6896628B2 (ja) 細菌感染症の治療のための抗微生物性ポリミキシン
JP5068813B2 (ja) 新規なベンゾチアジノン誘導体、及び抗菌剤としてのその使用
RU2006135541A (ru) Производные аминокислот
JP2008531713A5 (cg-RX-API-DMAC7.html)
JP2019535723A5 (cg-RX-API-DMAC7.html)
JP2016536360A5 (cg-RX-API-DMAC7.html)
JP2006515866A5 (cg-RX-API-DMAC7.html)
JP2007500222A5 (cg-RX-API-DMAC7.html)
US9034894B2 (en) Derivate, preparation method and use of 10-methoxycamptothecin
Foroumadi et al. Synthesis, in vitro‐Antimycobacterial Activity and Cytotoxicity of Some Alkyl α‐(5‐aryl‐1, 3, 4‐thiadiazole‐2‐ylthio) acetates
CA2436958A1 (fr) Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation
RU2003134629A (ru) Соединения цефема
JP2025072404A (ja) コンジュゲート
JPWO2021133896A5 (cg-RX-API-DMAC7.html)
JP2008531701A5 (cg-RX-API-DMAC7.html)
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина